Advanced search
Publication Cover
Cancer Investigation Volume 14, 1996 - Issue 4
Submit an article Journal homepage
25
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Clinical Pharmacokinetics of Amonafide (NSC 308847) in 62 Patients

W. Kreis North Shore University Hospital Cornell University Medical College Manhasset, New York, 11030
,
K. Chan University of Minnesota Minneapolis, Minnesota, 55455
,
D. R. Budman North Shore University Hospital Cornell University Medical College Manhasset, New York, 11030
,
S. L Allen North Shore University Hospital Cornell University Medical College Manhasset, New York, 11030
,
D. Fusco North Shore University Hospital Cornell University Medical College Manhasset, New York, 11030
,
A. Mittelman New York Medical College Valhalla, New York, 10595
,
J. Freeman North Shore University Hospital Cornell University Medical College Manhasset, New York, 11030
,
K. Hock North Shore University Hospital Cornell University Medical College Manhasset, New York, 11030
,
S. Akerman North Shore University Hospital Cornell University Medical College Manhasset, New York, 11030
,
A. Calabro North Shore University Hospital Cornell University Medical College Manhasset, New York, 11030
,
C. Puccio New York Medical College Valhalla, New York, 10595
&
M. Spigelman Knoll Pharmaceuticals Whippany, New Jersey, 07981
 show all
Pages 320-327 | Published online: 11 Jun 2009

References

  • Brana M F, Castellano J M, Roldan C M, et al. Synthesis and mode of action of a new class of imide derivatives of 3-nitro-1,8-naphthalic acid. Cancer Chemother Pharmacol 1980; 4: 61–66
  • Anderson B S, Beran M, Bakic M, et al. In vitro toxicity and DNA cleaving capacity of benzisoquinolidione (nafidimide; NSC 308847) in human leukemia. Cancer Res 1987; 47: 1040–1044
  • Hsiang Y H, Jiang J B, Liu L F. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs. Mol Pharmacol 1989; 36: 371–376
  • Zee-Cheng R KY, Cheng C C. N-(aminoalkyl) imide antineoplastic agents: Synthesis and biological activity. J Med Chem 1985; 28: 1216–1222
  • Craig J, Crawford E. Phase II trial of Amonafide in advanced prostate cancer. Proc Am Soc Clin Oncol 1989; 8: 147
  • Constanza M E, Korzun A H, Henderson I C, et al. Amonafide: An active agent in metastatic breast cancer (CALGB 8642). Proc ASCO 1990; 9: 31
  • O'Brien S, Bienvenito J A, Estey E, et al. Phase I clinical investigation of benzisoquinolione dione (amonafide) in adults with refractory or relapsed acute leukemia. Cancer Res 1991; 51: 935–938
  • Allen S L, Budman D R, Fusco D, et al. Phase I trial of amonafide for refractory, relapsed or secondary acute leukemias and blast crisis of chronic myelogenous leukemia. Proc ASCO 1992; 11: 276
  • Lu K, Legha S, Savaraj N, et al. Clinical pharmacology of nafidimide (BIDA, NSC-309947). Proc ASCO 1986; 5: 53
  • Malspeis L, Salam M A, Staubus A E, et al. Pharmacokinetics and metabolism of nafidimide (NSC 308847) in patients following single I.V. bolus administration. Proc AACR 1986; 27: 169
  • Ratain M J, Berezin M S, Allen S L, et al. Rapid acetylators of amonafide (BIDA) have enhanced myelosuppression. Clin Pharmacol Ther 1991; 49: 196, (abstract)
  • Felder T B, McLean M A, Vestal M L, et al. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC 308847) in humans. Drug Metab Dispos 1987; 15: 773–778
  • Ratain M J, Mick R, Berezin F, et al. Paradoxical relationship between acetylator phenotype and amonafide toxicity. Clin Pharm Ther 1991; 5: 573–579
  • Ratain M J, Mick R, Berezin F, et al. Phase I study of amonafide dosing based on acetylator phenotype. Cancer Res 1993; 53: 2304–2308
  • Ratain M J, Stanbris A E, Malspeis L. Limited sampling models for amonafide (NSC 308847) pharmacokinetics. Cancer Res 1988; 48: 4127–4130
  • Chan K K, Gibaldi M. Estimation of statistical moments and steady state volume of distribution for a drug given by intravenous infusion. J Pharm Pharmacokinet 1982; 10: 551–558
  • PCNONLIN, Version 4.0, Software for the statistical analysis of nonlinear models on micros. SCI Software, Apex, NC 27502
  • Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. Marcel Dekker, New York 1982
  • Legha S, Tenney D, Lu K, et al. Phase I study of benzisoquinoline (BIDA), nafidimide (NSC-308847). Proc AACR 1986; 27: 171
  • Saez R, Craig J B, Kuhn J G, et al. Phase I clinical investigation of amonafide. J Clin Oncol 1989; 7: 1351–1358
  • Lu K, Osterman C, Robbins V W, Newman A. Pharmacokinetics of nafidimide (BIDA, NSC-309947) in dogs. Proc AACR 1986; 27: 405
  • Allen S L, Budman D R, Fusco D, et al. Phase I trial of amonafide plus cytosine arabinoside for poor risk acute leukemias. Proc AACR 1994; 35: 225

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.